title: New treatments in cluster headache.
abstract: Cluster headache is the most severe headache syndrome known to humans. In most instances, this disorder is readily treatable when the correct medications are utilized at the correct dosages. Cluster treatment involves abortive, transitional, and preventive therapy strategies, all of which are discussed in this article.
authors.affiliation: Department of Neurology T33, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. RozenT@ccf.org
authors.forename: Todd D
authors.initials: TD
authors.lastname: Rozen
mesh_terms: D000779:Anesthetics, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines; D003027:Cluster Headache / Q000188:drug therapy / Q000628:therapy*; D004878:Ergotamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use*; D000077152:Olanzapine; D010100:Oxygen / Q000627:therapeutic use*; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D018170:Sumatriptan / Q000008:administration & dosage / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000779:Anesthetics, Local; D001569:Benzodiazepines; D004878:Ergotamine; D008012:Lidocaine; D000077152:Olanzapine; D010100:Oxygen; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors; D018170:Sumatriptan; D014662:Vasoconstrictor Agents